Chapters

Transcript

Video

Jennifer Brown, MD, PhD reviews Phase 2 Amplify trial

Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.


Published

January 9, 2025

Created by

Dana-Farber

Related Presenters

Jennifer R. Brown, MD, PhD

Jennifer R. Brown, MD, PhD

Medical Oncology

Jennifer R. Brown, MD, PhD is the Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School in Boston, Massachusetts.

View Full Profile